Luis A. Moreno Aznar
University of Zaragoza
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Luis A. Moreno Aznar.
Maternal and Child Nutrition | 2010
Blanca Román-Viñas; Adriana Ortiz-Andrellucchi; Michelle A. Mendez; Almudena Sánchez-Villegas; Luis Peña Quintana; Luis A. Moreno Aznar; Maria Hermoso; Lluis Serra-Majem
The objective of this study was to review how accurately micronutrient intakes in infants, children, and adolescents were assessed with validated food frequency questionnaires (FFQs) to which study quality criteria had been applied. The methodology and the analysis presented were based on several research activities carried out within the European Micronutrient Recommendation Aligned Network of Excellence. The analysis was limited to vitamin D, vitamin C, vitamin B₁₂, folate, selenium, iron, zinc, iodine, calcium, and copper. A search strategy was defined in MEDLINE and EMBASE literature for studies validating FFQs that estimated intakes of micronutrients being evaluated. Identification of at least three validation studies per micronutrient was required to be included in the analysis. A total score for each nutrient was calculated from the mean of the correlation coefficients weighted by the quality of the study, which included a quality score that was based on sample size, statistics used, data collection procedure, consideration of seasonality and supplement use, an adjustment/weighting of the correlation coefficient according to the quality score, and a rating of the adjusted/weighted correlation. When the mean weighted correlation coefficient was equal to or higher than 0.5, micronutrient intake was considered as adequately estimated. Sufficient validation studies were identified for vitamin C, vitamin D, vitamin B₁₂, iron, zinc, and calcium for infants and pre-school children, and vitamin C, calcium, and iron for older children and adolescents. Results showed that the FFQ was a good instrument for estimating intake of vitamin C, vitamin D, calcium, zinc and iron in infants and pre-school children, and for estimating calcium and vitamin C in children and adolescents.
Nutricion Hospitalaria | 2013
Alba M. Santaliestra-Pasías; Juan Pablo Rey-López; Luis A. Moreno Aznar
Paediatric overweight continues to be a public health problem, and the etiology of obesity is multifactorial and complex. Dietary patterns, physical activity (PA) and sedentary behaviors are acknowledged as major behavioural determinants of obesity. New technologies and electronic based activities have produced a decrease in PA levels, and an increase in sedentary activities in children and adolescents. Potential mechanisms that explain the association between TV viewing and childhood obesity are: displacement of PA, unhealthy food preferences produced by food advertisements, a higher energy intake by automatic eating and overconsumption caused by distraction. Interventions aimed to reduce time in sedentary behaviours are in children generally positive. However, their benefits on adiposity markers are small. Thus, if global and macro-level obesogenic factors are not changed substantially, the interventions oriented to prevent obesity will produce small benefits.
Medicina Clinica | 2005
José L. López; Margarita Vázquez Olivares; Jesús Fleta Zaragozano; Luis A. Moreno Aznar; Manuel Sánchez
Fundamento y objetivo La obesidad esta asociada con factores de riesgo cardiovascular y fallo cardiaco. Sujetos y metodo Se comparo a 30 ninos que presentaban sobrepeso u obesidad con 30 ninos sanos. Se midieron los intervalos QT corregido (QTc), dispersion del QT (QTd), masa del ventriculo izquierdo, indice de masa del ventriculo izquierdo, fraccion de eyeccion y fraccion de acortamiento. Resultados Los intervalos QTc y QTd, masa del ventriculo izquierdo e indice de masa del ventriculo izquierdo fueron significativamente mayores en los ninos con sobrepeso u obesidad que en los controles. Conclusiones Los ninos con sobrepeso u obesidad tienen un incremento de los intervalos QTc, QTd, del volumen y masa del ventriculo izquierdo, y un mayor riesgo de arritmias que los controles. Estos resultados hacen considerar la necesidad de una especial monitorizacion cardiaca de los ninos obesos, en especial de los que tienen formas graves.
Nutricion Hospitalaria | 2014
Isidro Vitoria; Francisco Maraver; Cíntia Ferreira-Pêgo; Francisco Armijo; Luis A. Moreno Aznar; Jordi Salas-Salvadó
INTRODUCTION A sufficient intake of calcium enables correct bone mineralization. The bioavailability of calcium in water is similar to that in milk. OBJECTIVE To determine the concentration of calcium in public drinking water and bottled mineral water. METHODS We used ion chromatography to analyse the calcium concentrations of public drinking waters in a representative sample of 108 Spanish municipalities (21,290,707 people) and of 109 natural mineral waters sold in Spain, 97 of which were produced in Spain and 12 of which were imported. RESULTS The average calcium concentration of public drinking waters was 38.96 ± 32.44 mg/L (range: 0.40- 159.68 mg/L). In 27 municipalities, the water contained 50-100 mg/L of calcium and in six municipalities it contained over 100 mg/L. The average calcium concentration of the 97 Spanish natural mineral water brands was 39.6 mg/L (range: 0.6-610.1 mg/L). Of these, 34 contained 50-100 mg/L of calcium and six contained over 100 mg/L. Of the 12 imported brands, 10 contained over 50 mg/L. Assuming water consumption is as recommended, water containing 50-100 mg/L of calcium provides 5.4-12.8% of the recommended intake of calcium for children aged one to thirteen, up to 13.6% for adolescents, 5.8-17.6% for adults, and up to 20.8% for lactating mothers. Water with 100-150 mg/L of calcium provides 10-31% of the recommended dietary allowance, depending on the age of the individual. DISCUSSION Public drinking water and natural mineral water consumption in a third of Spanish cities can be considered an important complementary source of calcium.
BMJ Open | 2017
Miriam Garrido-Miguel; Iván Cavero-Redondo; Celia Álvarez-Bueno; Fernando Rodríguez-Artalejo; Luis A. Moreno Aznar; Jonatan R. Ruiz; Vicente Martínez-Vizcaíno
Introduction Increasing prevalence of both thinness and excess weight during childhood and adolescence is a significant public health issue because of short-term health consequences and long-term tracking of weight status. Monitoring weight status in Europe may serve to identify countries and regions where rates of these disorders are either slowing down or increasing to evaluate recent policies aimed at appropriate body weight, and to direct future interventions. This study protocol provides a standardised and transparent methodology to improve estimating trends of thinness, overweight and obesity in children aged 3–18 years and adolescents across the European region between 2000 and 2017. Methods and analysis This protocol is guided by the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) and the Cochrane Collaboration Handbook. To identify relevant studies, a search will be conducted in MEDLINE, EMBASE, Cochrane Library, CINAHL and Web of Science databases. From the selected studies, relevant references will be screened as supplemental sources. Finally, open search in websites from health institutions will be conducted to identify weight status data not published in scientific journals. Cross-sectional, follow-up studies and panel surveys reporting weight status (objectively measured height and weight) according to the International Obesity Task Force criteria, and written in English or Spanish will be included. Subgroup analyses will be carried out by gender, age, study year and country or European region. Discussion This study will provide a comprehensive description of weight status of children and adolescents across Europe from 2000 to 2017. The results will be disseminated in a peer-reviewed journal. This study will use data exclusively from published research or institutional literature, so institutional ethical approval is not required. PROSPERO registration number CRD42017056917.
Therapie | 2007
Germán Vicente-Rodríguez; Christian Libersa; M.I. Mesana; Laurent Béghin; Catalina Iliescu; Luis A. Moreno Aznar; Jean Dallongeville; Frédéric Gottrand
Nutricion Hospitalaria | 2013
Luis A. Moreno Aznar; Pilar Cervera Ral; Rosa María Ortega Anta; Juan José Díaz Martín; Eduard Baladia; Julio Basulto; Silvia Bel Serrat; Iris Iglesia Altaba; Ana M. López-Sobaler; Maria Manera; Elena M. Rodríguez Rodríguez; Alba María Santaliestra Pasías; Nancy Babio; Jordi Salas-Salvadó
Medicina Clinica | 1999
Jesús Fleta Zaragozano; Lilianne Mur de Frenne; Gerardo Rodríguez Martínez; Luis A. Moreno Aznar; Manuel Bueno Lozano; José L. López
Nutricion Hospitalaria | 2013
Gregorio Varela-Moreiras; Luis Fernando Alguacil Merino; Elena Alonso Aperte; Javier Aranceta Bartrina; José Manuel Ávila Torres; Susana Aznar Laín; Susana Belmonte Cortés; Lucio Cabrerizo García; María Ángeles Dal Re Saavedra; Alfonso Delgado Rubio; Marta Garaulet Aza; Pedro Pablo García Luna; Angel Gil Hernández; Marcela González-Gross; María Luisa López Díaz-Ufano; Ascensión Marcos Sánchez; Emilio Martínez de Victoria Muñoz; Vicente Martínez Vizcaíno; Luis A. Moreno Aznar; Juan José Murillo Ramos; José María Ordovás Muñoz; Mª Rosa Ortega Anta; Nieves Palacios Gil-Antuñano; Andreu Palou Oliver; Carmen Pérez Rodrigo; Pilar Riobó Serván; Lluís Serra Majem; Josep A. Tur Marí; Rafael Urrialde de Andrés; Salvador Zamora Navarro
Nutricion Hospitalaria | 2017
Esther M. González-Gil; Luis Gracia-Marco; Javier Santabárbara; Dénes Molnár; Francisco Jose Amaro Gahete; Frédéric Gottrand; Aline Arouca; A. Kafatos; Kurt Widhalm; Alfonso Siani; Marcela González-Gross; Sonia Gómez-Martínez; Ligia Esperanza Díaz; Catherine Leclerq; Jean Dallongeville; Ascensión Marcos; Luis A. Moreno Aznar